S 81694

· Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S 81694, covering 2021-05-25 to 2021-05-25. Get the full timeline:

Most recent: Clinical Trial Update: S 81694 Plus Paclitaxel in Metastatic Breast Cancer [Phase 1, Phase 2]